Recombinant Nitrosomonas europaea 3-dehydroquinate dehydratase (aroQ)

Shipped with Ice Packs
In Stock

Description

Enzyme Classification

  • Type II DHQD:

    • Utilizes an anti-dehydration mechanism via an enolate intermediate stabilized by conserved residues (e.g., Lys, Asp) .

    • Forms homododecamers with a flavodoxin-like fold, distinct from Type I enzymes (α/β barrel dimers) .

    • Catalyzes the reaction:

      3-Dehydroquinate3-Dehydroshikimate+H2O\text{3-Dehydroquinate} \rightarrow \text{3-Dehydroshikimate} + \text{H}_2\text{O}

Key Residues and Mutational Analysis

  • Pro105: A unique residue in Corynebacterium glutamicum DHQD near the substrate’s 5-hydroxyl group. Replacement with Ile/Val reduced activity by ~70%, while S103T increased activity by 10% .

  • Tyr24 and Asp88 (in Mycobacterium tuberculosis DHQD): Critical for stabilizing the enolate intermediate .

Genomic Features

  • N. europaea’s genome (2.8 Mbp, 50.7% GC) encodes 2,460 proteins, including enzymes for ammonia oxidation, CO2_2 fixation, and aromatic amino acid metabolism .

  • While aroQ is not explicitly annotated in current N. europaea genome databases, proteomic studies confirm the presence of shikimate pathway enzymes .

Metabolic Role

  • Autotrophic Carbon Fixation: Relies on the Calvin-Benson-Bassham (CBB) cycle, with RuBisCO as the primary CO2_2-fixing enzyme .

  • Link to Nitrogen Metabolism: DHQD may indirectly support redox balance during ammonia oxidation by producing aromatic precursors for stress-response molecules .

Cloning and Purification

  • Expression Systems: Escherichia coli is commonly used for heterologous expression of aroQ homologs (e.g., M. tuberculosis) due to high yields and ease of purification .

  • Kinetic Parameters:

    OrganismKmK_m (μM)kcatk_{cat} (s1^{-1})kcat/Kmk_{cat}/K_m (M1^{-1}s1^{-1})
    C. glutamicum12045375,000
    M. tuberculosis8552611,764
    Data from structural studies

Biotechnological Potential

  • Antimicrobial Targets: Type II DHQD is absent in humans, making it a candidate for drug development against pathogens (e.g., M. tuberculosis) .

  • Bioremediation: N. europaea’s ability to degrade halogenated compounds (e.g., trichloroethylene) could be enhanced via aroQ engineering .

Research Gaps and Future Directions

  • Structural Data: No crystal structures of N. europaea DHQD are available, limiting mechanistic insights.

  • Regulatory Networks: The interplay between DHQD and nitrogen metabolism (e.g., nitrite reductase NirK) under oxygen-limited conditions remains unexplored .

Product Specs

Form
Lyophilized powder

Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.

Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.

Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.

The tag type is determined during production. To ensure a specific tag type, please inform us beforehand, and we will prioritize its inclusion.

Synonyms
aroQ; aroQ1; NE06513-dehydroquinate dehydratase; 3-dehydroquinase; EC 4.2.1.10; Type II DHQase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-144
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Nitrosomonas europaea (strain ATCC 19718 / CIP 103999 / KCTC 2705 / NBRC 14298)
Target Names
aroQ
Target Protein Sequence
MAANILVIHG PNLNLLGRRE PAVYGQTTLE DINRNLTVKA QAAPVALSIF QSNAEHELID RVQGAMSDGT DFIIINPAAL THTSIALRDA LAATSLPFVE IHLSNVYARE SFRRTSYFSD IAVGVISGLG AAGYELALQF ALTR
Uniprot No.

Target Background

Function

Catalyzes a trans-dehydration reaction via an enolate intermediate.

Database Links

KEGG: neu:NE0651

STRING: 228410.NE0651

Protein Families
Type-II 3-dehydroquinase family

Q&A

What is Nitrosomonas europaea and what ecological significance does it have?

Nitrosomonas europaea is an obligate chemolithoautotrophic bacterium that derives all its energy and reducing power from the oxidation of ammonia to nitrite. It plays a crucial role in the biogeochemical nitrogen cycle through nitrification, converting reduced nitrogen (ammonia/ammonium) to oxidized forms (nitrite). As a member of the β-subdivision of proteobacteria, N. europaea has the remarkable ability to fix carbon dioxide to meet its carbon requirements while utilizing inorganic nutrients for growth .

The ecological significance of N. europaea extends to multiple environmental processes. While nitrification can produce greenhouse gases (NO and N₂O) and contribute to nitrogen leaching in water bodies, it also increases nitrogen availability to plants, supports wastewater treatment processes, and shows potential for bioremediation of sites contaminated with chlorinated aliphatic hydrocarbons .

What is the role of 3-dehydroquinate dehydratase (aroQ) in Nitrosomonas europaea metabolism?

The 3-dehydroquinate dehydratase (aroQ) enzyme catalyzes the conversion of 3-dehydroquinic acid (DHQ) to 3-dehydroshikimic acid in the middle stage of the shikimate pathway . This pathway is essential for the biosynthesis of aromatic amino acids (phenylalanine, tyrosine, and tryptophan) and folates, which are vital for cellular function.

In N. europaea, the aroQ enzyme belongs to the type II DHQD family and plays a critical role in the organism's ability to synthesize these essential compounds. Unlike heterotrophic organisms that can acquire aromatic amino acids from their environment, N. europaea must synthesize these compounds de novo due to its autotrophic lifestyle, making the shikimate pathway and the aroQ enzyme particularly important for its survival and growth .

How does aroQ function differ between N. europaea and other bacterial species?

Most notably, N. europaea aroQ possesses a distinctive residue (P105) not conserved in other DHQDs at the position near the 5-hydroxyl group of the substrate . This unique residue may contribute to specific catalytic properties or substrate binding characteristics that differentiate the N. europaea enzyme from its counterparts in other organisms.

What expression systems are available for producing recombinant N. europaea aroQ and what are their comparative advantages?

Recombinant N. europaea aroQ can be expressed in multiple systems, each offering distinct advantages depending on research objectives:

Expression SystemAdvantagesLimitationsOptimal Use Cases
E. coliHigh yield, rapid growth, cost-effective, well-established protocolsLimited post-translational modifications, potential inclusion body formationInitial characterization, structural studies, high-throughput screening
YeastEukaryotic post-translational modifications, secretion capabilities, moderate yieldLonger culture time than E. coli, hyperglycosylation possibleStudies requiring certain eukaryotic modifications
BaculovirusAdvanced eukaryotic post-translational modifications, high expression levelsTechnical complexity, higher cost, longer production timeComplex functional studies, when mammalian-like modifications are required
Mammalian cellsMost authentic post-translational modifications, native-like protein foldingHighest cost, lowest yield, technical complexityStudies focusing on protein-protein interactions or requiring precise modifications

What are the methodological considerations for optimizing aroQ solubility and activity in heterologous expression systems?

Optimizing aroQ solubility and activity in heterologous expression systems requires careful consideration of several factors:

Temperature optimization: Lower induction temperatures (16-25°C) often improve protein folding and solubility for bacterial enzymes like aroQ. Conducting small-scale expression trials at varying temperatures (37°C, 30°C, 25°C, 18°C) can help identify optimal conditions.

Induction parameters: The concentration of inducer (e.g., IPTG for E. coli systems) and induction timing significantly impact protein solubility. Lower inducer concentrations (0.1-0.5 mM IPTG) and induction during mid-log phase often yield better results for enzymatic proteins.

Fusion tags selection: For N. europaea aroQ, solubility-enhancing tags like MBP (maltose-binding protein) or SUMO can improve folding. While the product information notes that "tag type will be determined during the manufacturing process," researchers should consider the impact of different tags on downstream applications .

Buffer optimization: The buffer composition during lysis and purification critically affects enzyme stability. For aroQ, buffers containing glycerol (10-20%), reducing agents (1-5 mM DTT or β-mercaptoethanol), and appropriate pH (typically 7.0-8.0) help maintain enzyme stability and activity.

Codon optimization: Adapting the N. europaea aroQ gene sequence to the codon usage bias of the expression host can significantly improve translation efficiency and protein yield, particularly when expressing in evolutionarily distant hosts.

What is known about the structural features of N. europaea aroQ and how do they relate to its catalytic function?

The N. europaea aroQ enzyme belongs to the type II dehydroquinate dehydratase family. The full-length protein consists of 144 amino acids with the amino acid sequence starting with MAANILVIHG and ending with FALTR . Structural analyses reveal that type II DHQDs typically form homo-dodecameric assemblies composed of dimeric units, creating a catalytically active quaternary structure.

The distinctive feature of N. europaea aroQ is the presence of residue P105 near the substrate's 5-hydroxyl group binding site, which is not conserved in other DHQDs . This unique residue may influence substrate binding specificity or catalytic efficiency.

The catalytic mechanism of type II DHQDs involves a base-catalyzed anti-elimination of water across the C1-C6 bond of the substrate. Key catalytic residues typically include a conserved tyrosine that acts as a general base to abstract a proton from C2, and a histidine that facilitates the departure of the hydroxyl group from C1. While the specific catalytic residues in N. europaea aroQ are not explicitly identified in the search results, based on homology with other type II DHQDs, similar mechanisms likely apply.

How does the enzyme kinetics of recombinant N. europaea aroQ compare with the native enzyme and those from other organisms?

While the search results don't provide specific kinetic parameters for N. europaea aroQ, a methodological approach to addressing this question would involve:

  • Expression and purification of both native and recombinant enzymes: Native enzyme would be isolated directly from N. europaea cultures, while recombinant versions would be produced in various expression systems (E. coli, yeast, etc.).

  • Kinetic parameter determination: Standard enzyme assays would measure Km, kcat, and catalytic efficiency (kcat/Km) using 3-dehydroquinate as substrate.

  • Comparative analysis: The following table illustrates how such a comparison might be structured:

Enzyme SourceKm (μM)kcat (s⁻¹)kcat/Km (M⁻¹s⁻¹)Optimal pHTemperature Optimum (°C)
Native N. europaea[value][value][value][value][value]
Recombinant (E. coli)[value][value][value][value][value]
Recombinant (Yeast)[value][value][value][value][value]
Other organism 1[value][value][value][value][value]
Other organism 2[value][value][value][value][value]

Such a comparison would reveal whether heterologous expression affects enzyme performance and how N. europaea aroQ compares with homologous enzymes from other species, providing insights into potential evolutionary adaptations related to N. europaea's chemolithoautotrophic lifestyle.

What are the optimal conditions for assaying N. europaea aroQ activity in vitro?

The optimal conditions for assaying N. europaea aroQ activity should be established through systematic parameter optimization:

Buffer composition: A standard assay buffer would typically contain:

  • 50 mM Tris-HCl or phosphate buffer (pH 7.0-8.0)

  • 100-150 mM NaCl for ionic strength

  • 1-5 mM DTT or β-mercaptoethanol as reducing agent

  • 5-10% glycerol for stability

pH optimization: The activity should be tested across a pH range (5.0-9.0) to determine the optimum. Type II DHQDs typically show maximal activity in the pH range of 7.0-8.0.

Temperature range: Activity measurements at temperatures ranging from 25-50°C would help identify the temperature optimum, with consideration of N. europaea's natural growth conditions.

Substrate concentration: A range of 3-dehydroquinate concentrations (typically 10 μM to 1 mM) should be tested to establish Michaelis-Menten kinetics.

Detection methods: Activity can be monitored by:

  • Spectrophotometric measurement of product formation at 234 nm (absorption maximum of the unsaturated product)

  • HPLC analysis of substrate consumption and product formation

  • Coupled enzyme assays that link product formation to a colorimetric or fluorometric readout

When designing assays, it's important to consider the unique metabolic context of N. europaea, which functions in an ammonia-oxidizing environment with specific oxygen requirements .

How can researchers effectively design site-directed mutagenesis experiments to probe the function of specific residues in N. europaea aroQ?

Designing effective site-directed mutagenesis experiments for N. europaea aroQ requires a systematic approach:

  • Target residue identification: Focus on:

    • Conserved catalytic residues (based on homology with characterized type II DHQDs)

    • The distinctive P105 residue unique to N. europaea aroQ

    • Residues involved in substrate binding or quaternary structure formation

  • Mutagenesis strategy:

    • Conservative substitutions: Replace with amino acids of similar properties to probe subtle effects

    • Non-conservative substitutions: Replace with functionally distinct amino acids to test essential nature

    • Alanine scanning: Systematically replace residues with alanine to eliminate side-chain functions

  • Experimental validation framework:

    • Express and purify mutant proteins under identical conditions

    • Assess structural integrity through circular dichroism or thermal stability assays

    • Determine kinetic parameters (Km, kcat) for each mutant

    • Evaluate quaternary structure through analytical ultracentrifugation or size-exclusion chromatography

  • Data analysis template:

MutationExpression LevelStructural ImpactKm (μM)kcat (s⁻¹)kcat/Km (M⁻¹s⁻¹)Oligomeric State
Wild-type[baseline][baseline][value][value][value][state]
P105A[% of WT][observation][value][value][value][state]
P105S[% of WT][observation][value][value][value][state]
[Cat1]A[% of WT][observation][value][value][value][state]

This methodical approach would provide insights into the specific roles of residues unique to N. europaea aroQ, potentially revealing adaptations related to the organism's unusual metabolism as an ammonia oxidizer .

How can recombinant N. europaea aroQ be used to investigate microgravity effects on nitrification pathways?

Recent research has explored the effects of simulated microgravity (SMG) on N. europaea in tripartite communities with Comamonas testosteroni and Nitrobacter winogradskyi . Building on this foundation, recombinant N. europaea aroQ could serve as a model system for investigating microgravity effects on metabolic pathways:

  • Comparative enzyme activity studies:

    • Express and purify recombinant N. europaea aroQ under normal gravity (NG) and simulated microgravity (SMG) conditions

    • Compare enzyme kinetics, stability, and structural properties

    • Assess the impact of microgravity on post-translational modifications that might affect catalytic activity

  • Integration with transcriptomics data:

    • Correlate changes in aroQ expression levels under microgravity (as observed in whole transcriptome analysis ) with enzyme activity measurements

    • Develop a metabolic flux model incorporating aroQ activity to predict pathway shifts under microgravity

  • Experimental design for space station experiments:

    • Use recombinant aroQ as a model enzyme for pre-flight testing

    • Design stabilized enzyme formulations suitable for spaceflight experiments

    • Create biosensor systems using aroQ to monitor shikimate pathway activity in real-time during spaceflight

This approach would provide valuable insights into how microgravity affects essential metabolic pathways in bacteria relevant to regenerative life support systems (RLSS) for long-duration space missions. The existing research showing that N. europaea comprised approximately 19-23% of the tripartite community under different gravity conditions provides context for interpreting aroQ-specific effects .

What are the potential applications of N. europaea aroQ in studying nutrient limitation responses in chemolithoautotrophs?

N. europaea aroQ can serve as a molecular probe for investigating nutrient limitation responses in chemolithoautotrophs, providing insights into metabolic adaptations:

Nutrient LimitationGrowth RatearoQ mRNA LevelaroQ Protein LevelEnzyme ActivityAromatic AA Pools
None (control)[value][value][value][value][value]
Ammonia limitation[value][value][value][value][value]
CO₂ limitation[value][value][value][value][value]
Phosphate limitation[value][value][value][value][value]
O₂ limitation[value][value][value][value][value]

This research would provide insights into how specialized organisms like N. europaea balance competing metabolic demands under resource constraints, with potential applications to bioremediation and wastewater treatment where these organisms often face variable nutrient conditions .

How might the distinctive P105 residue in N. europaea aroQ be exploited for enzyme engineering applications?

The distinctive P105 residue in N. europaea aroQ provides a unique opportunity for enzyme engineering applications :

  • Substrate specificity engineering:

    • The unique P105 residue near the substrate's 5-hydroxyl group binding site could be exploited to alter substrate recognition

    • Creating a library of P105X mutations might yield variants with altered specificity for modified substrates

    • This could enable the enzymatic production of novel shikimate pathway intermediates for pharmaceutical applications

  • Stability enhancement strategies:

    • Proline residues often contribute to protein rigidity and thermostability

    • The distinctive P105 might be part of a structural feature that could be leveraged to enhance stability

    • Combining P105 modifications with additional stabilizing mutations could yield enzymes suitable for industrial applications

  • Methodological approach to P105-focused engineering:

    • Create a comprehensive P105X library (all 19 possible amino acid substitutions)

    • Develop high-throughput screening methods to assess activity on standard and modified substrates

    • Characterize promising variants through detailed kinetic and structural analyses

    • Use computational modeling to predict additional modifications that might synergize with P105 alterations

  • Potential applications in synthetic biology:

    • Engineered aroQ variants could be incorporated into synthetic pathways for producing high-value aromatic compounds

    • N. europaea's chemolithoautotrophic metabolism provides a unique context that might be advantageous for certain bioproduction scenarios

    • Combining aroQ engineering with whole-cell approaches could yield novel biocatalysts for environmental applications

This research direction would build upon the structural insights into N. europaea aroQ while leveraging the organism's unique metabolic capabilities as an ammonia oxidizer .

What research gaps remain in understanding the integration of the shikimate pathway with nitrogen metabolism in N. europaea?

Several significant research gaps remain in understanding how the shikimate pathway (including aroQ) integrates with nitrogen metabolism in N. europaea:

  • Regulatory interconnections:

    • How nitrogen availability affects shikimate pathway enzyme expression and activity remains poorly characterized

    • The potential role of transcriptional regulators that respond to both nitrogen status and aromatic amino acid pools needs investigation

  • Metabolic flux distribution:

    • How N. europaea balances carbon allocation between central metabolism and the shikimate pathway under different ammonia oxidation rates is unclear

    • Quantitative metabolic flux analysis under various nitrogen conditions would provide valuable insights

  • Energy coupling mechanisms:

    • N. europaea derives energy from ammonia oxidation , but how this energy budget influences biosynthetic pathways like the shikimate pathway remains unexplored

    • The potential for direct coupling between ammonia oxidation and biosynthetic reactions warrants investigation

  • Research methodology approaches:

    • Multi-omics integration: Combine transcriptomics, proteomics, and metabolomics to track pathway responses to environmental changes

    • Isotope labeling studies: Use ¹³C and ¹⁵N labeled substrates to track atomic flows between nitrogen and carbon metabolism

    • Genetic manipulation: Develop improved genetic tools for N. europaea to enable precise modification of regulatory elements

  • Proposed experimental framework:

Research QuestionExperimental ApproachExpected OutcomesBroader Implications
How does ammonia availability affect aroQ expression?qRT-PCR and proteomic analysis across ammonia concentrationsCorrelation between N availability and shikimate pathway regulationInsight into autotroph resource allocation
What transcription factors regulate aroQ?ChIP-seq and DNA binding assaysIdentification of regulatory proteinsPotential targets for metabolic engineering
How is carbon partitioned between shikimate pathway and other needs?¹³C flux analysis under varying ammonia oxidation ratesQuantitative flux mapsUnderstanding of chemolithoautotroph metabolic strategies

Addressing these gaps would enhance our understanding of how specialized organisms like N. europaea coordinate essential biosynthetic pathways with their unusual energy metabolism, potentially informing applications in bioremediation, wastewater treatment, and synthetic biology .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.